Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Josh Bedel"'
Publikováno v:
Pharmacoeconomics
Objectives The aim was to evaluate the cost-effectiveness of niraparib compared with routine surveillance (RS), olaparib and rucaparib for the maintenance treatment of patients with recurrent ovarian cancer (OC). Methods A decision-analytic model est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae1697f37c17f350100512cf4b35af8
https://doi.org/10.1007/s40273-019-00815-3
https://doi.org/10.1007/s40273-019-00815-3
Autor:
Andrew R Clamp, Giovanni Scambia, Jesús García-Donas, Robert W. Holloway, Amit M. Oza, Juliette Meunier, Nicoletta Colombo, Robert L. Coleman, Lara Maloney, Alexandra Leary, Margarita Amenedo Gancedo, Ana Oaknin, David M. O'Malley, Sandra Goble, Josh Bedel, Deborah K. Armstrong, Peter C.C. Fong, Jeffrey C. Goh, Carol Aghajanian, Domenica Lorusso, Johanne I Weberpals, Elizabeth M. Swisher, Jonathan A. Ledermann, Susana Banerjee, Terri Cameron, Andrew Dean
Publikováno v:
Scientia
Gynecologic oncology
Gynecologic oncology
Pacients d'edat avançada; Càncer d'ovaris; Inhibidor de la PARP Pacientes de edad avanzada; Cáncer de ovarios; Inhibidor de PARP Elderly patients; Ovarian cancer; PARP inhibitor Background In the phase 3 trial ARIEL3, maintenance treatment with th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d7005aea5c1c77d6850dc9f329a5a6
http://hdl.handle.net/10807/167340
http://hdl.handle.net/10807/167340
Autor:
Peter C.C. Fong, Ann Christin Mörk, Carol Aghajanian, Giovanni Scambia, David Cella, Josh Bedel, Deborah K. Armstrong, Juliette Meunier, Robert W. Holloway, Ana Oaknin, Lara Maloney, Alexandra Leary, Johanne I Weberpals, Margarita Amenedo Gancedo, Elizabeth M. Swisher, Andrew R Clamp, Jeffrey C. Goh, Sandra Goble, Andrew Dean, Domenica Lorusso, David M. O'Malley, Jesús García-Donas, Amit M. Oza, Susana Banerjee, Terri Cameron, Jonathan A. Ledermann, Nicoletta Colombo, Robert L. Coleman
Publikováno v:
Journal of Clinical Oncology
Scientia
Scientia
Carcinoma d'ovari recurrent; Rucaparib Carcinoma de ovario recurrente; Rucaparib Recurrent Ovarian Carcinoma; Rucaparib PURPOSE To investigate quality-adjusted progression-free survival (QA-PFS) and quality-adjusted time without symptoms or toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de4b91b79cf28241c1fc82a95b633d4d
http://hdl.handle.net/10281/291278
http://hdl.handle.net/10281/291278
Autor:
M. Amenedo Gancedo, Nicoletta Colombo, Andrew R Clamp, Robert L. Coleman, Elizabeth M. Swisher, Susana Banerjee, Domenica Lorusso, Robert W. Holloway, Peter C.C. Fong, T. Cameron, Carol Aghajanian, Johanne I Weberpals, Jeffrey C. Goh, Josh Bedel, Jonathan A. Ledermann, David M. O'Malley, Amit M. Oza, Juliette Meunier, Ana Oaknin, J García-Donas, Giovanni Scambia, Andrew Dean, Sandra Goble, Alexandra Leary, D. K. Armstrong, Lara Maloney
Publikováno v:
Oral Communication 3 – Ovarian Cancer.
Introduction/Background Maintenance therapy for recurrent ovarian cancer is intended to extend progression-free survival (PFS) without compromising patient quality of life; therefore, the clinical benefits of prolonged PFS should be evaluated in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae8edd3ae5fda35c960995308c263241
https://doi.org/10.1136/ijgc-2019-esgo.29
https://doi.org/10.1136/ijgc-2019-esgo.29
Autor:
Josh Bedel, Andrew R Clamp, T. Cameron, Peter C.C. Fong, Giovanni Scambia, Sandra Goble, Carol Aghajanian, Andrew Dean, Johanne I Weberpals, Jeffrey C. Goh, Ana Oaknin, Nicoletta Colombo, Domenica Lorusso, Robert L. Coleman, M. Amenedo Gancedo, Jonathan A. Ledermann, Alexandra Leary, Robert W. Holloway, David M. O'Malley, Amit M. Oza
Publikováno v:
Plenary sessions.
Objectives In ARIEL3, rucaparib maintenance treatment significantly improved progression-free survival (PFS) vs placebo. A prespecified exploratory analysis investigated postprogression outcomes. Additionally, a post hoc exploratory analysis investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4247bf487f8176f7822e5aa8449cd321
https://doi.org/10.1136/ijgc-2019-igcs.2
https://doi.org/10.1136/ijgc-2019-igcs.2